Avid Bioservices Inc (CDMO)

[2ndstr2thert]

Chris thank you for your article. You have written the lay-friendly informative PR that PPHM(TCLN)never produced in the 20+ years I have owned this stock.I sincerely hope you have started a retail revolution.IMO shedding a light on the risk vs reward ratio vis a vis PPHM will hopefully attract enough long investors(like many of us on this board )to raise the share price so we can: 1) gain leverage in negotiations
2) increase visibility
3) decrease dilution
4) help cancer patients
5) give all who have supported this co. through the years a profit.I was in my early 40's when I first invested now I just turned 67. I get the "no pain no gain " concept but this is starting to get ridiculous. Father time knocks on everyones door even management's -bring this saga to a succesful conclusion in a reasonable timeframe(< 2018 ).

May I suggest you use your writing skills and scientific knowlege to pen a piece:
1) Explaining why bavi is unique ( upsteam,safety,M1 state inducer,multiple combo possibilities,imaging, non cancer applications)among the current crop of immunostimulatory drugs.
2) Explain why the FDA approved the NSCL phase 3 trial with "fast tract status" inspite of the sabotage of the phase 2 trial.Why many of usbelieve that the statistics involved with the 3 mg. dose vs the revamped control arm indicates that bavituximab is far superior to the soc.

Once again thanks-just the right amount of professionalism and sizzle.